🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas Sandmann

Denali Therapeutics (United States)

ORCID: 0000-0002-6601-8890

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia”.

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Molecular Neurodegeneration(2022)10.1186/s13024-022-00547-7

N/A

0DataRank · unranked

126 citations

Steve Lianoglou, Thomas Sandmann, Meredith Calvert, Jung H. Suh, Elliot R. Thomsen +43 more

Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes

Cell(2024)10.1016/j.cell.2024.10.027

N/A

0DataRank · unranked

86 citations

Dylan Braun, Gabriel A. Fitzgerald, Yun-Ting Hsieh, Lionel Rougé, Alexandra Litvinchuk +37 more

Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial

Nature Communications(2025)10.1038/s41467-025-63031-y

N/A

0DataRank · unranked

11 citations

Seungyoon B. Yu, Isaac Cohen, Melania H. Fanok, Wei Luan, Romeo Maciuca +38 more